Vaccine · BLA
Shingrix (Zoster vaccine recombinant, adjuvanted) NDC 50090-7919
Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL · Injection, Solution · Intramuscular · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-7919-0 | 50090791900 | 1 mL in 1 KIT (50090-7919-0)Marketed from Jul 16, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Shingrix
- Generic name (nonproprietary)
- zoster vaccine recombinant, adjuvanted
- Active ingredients
- Recombinant varicella zoster virus glycoprotein e antigen — 50 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125614
- Marketing start
- Listing expires
- Identifiers
- Product ID 50090-7919_3cc5ee17-3376-493a-8146-42df66edb945SPL ID 3cc5ee17-3376-493a-8146-42df66edb945
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeMed-Code curated
CPT 90750 — Vaccine product code for SHINGRIX (zoster vaccine recombinant, adjuvanted)
Billing unit: 1 dose. Units on the claim = dose given ÷ 1 dose.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N450090791900followed by a unit qualifier and the quantityPackage 50090-7919-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 50090-7919
- What is NDC 50090-7919?
- 50090-7919 is the product NDC for Shingrix, Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL injection, solution, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Shingrix (Zoster Vaccine Recombinant, Adjuvanted).
- What is the active ingredient?
- Recombinant varicella zoster virus glycoprotein e antigen.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Shingrix?
- 2 other product NDCs are listed under this name. See all Shingrix NDCs.
- Is there a related HCPCS / J-code?
- Yes: 90750, Vaccine product code for SHINGRIX (zoster vaccine recombinant, adjuvanted). See Billing references above.
Related NDCs: other Shingrix products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Shingrixzoster vaccine recombinant, adjuvanted | Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL | Injection, SolutionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-849 | 58160-0849-52 |
| Shingrixzoster vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-823 | 58160-0823-11 |
Other NDCs under BLA 125614
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Shingrixzoster vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-823 |
| Shingrixzoster vaccine recombinant, adjuvanted | Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL | Injection, SolutionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-849 |